Health Care Industry

Blog Posts

USC-Brookings Schaeffer on Health Policy

Some drugs that improve price competition fall through the cracks of FDA user fees

Marta E. Wosińska and Richard G. Frank

Monday, December 12, 2022

Up Front

The role of immigrants in the market for elder care

Kristin F. Butcher, Kelsey Moran, and Tara Watson

Friday, November 4, 2022

USC-Brookings Schaeffer on Health Policy

Multi-year Medicare physician fee freeze threatens access: Pair relief with reforms

Paul B. Ginsburg and Steven M. Lieberman

Wednesday, October 26, 2022

View All Blog Posts

Events

Related Books

Toward a Containment Strategy for Smallpox Bioterror

By Joshua M. Epstein, Derek A. T. Cummings, Shubha Chakravarty, Ramesh M. Singha, and Donald S. Burke

2004

Coping with Methuselah

Edited by Henry Aaron and William B. Schwartz

2004

View All Books

Experts

Loren Adler

Fellow and Associate Director - USC-Brookings Schaeffer Initiative for Health Policy

@LorenAdler

Richard G. Frank

Senior Fellow - Economic Studies

Director - USC-Brookings Schaeffer Initiative for Health Policy

Erin Trish

Co-director - USC Schaeffer Center for Health Policy & Economics

Nonresident Fellow - Economic Studies, USC-Brookings Schaeffer Initiative for Health Policy

View All Experts

Multimedia

Up Front

Post-election town hall: Possible policy impacts on the social determinants of health

Stuart M. Butler and Nehath Sheriff

Friday, November 20, 2020

Rev. Dr. William J. Barber speaks during a protest against the repeal of the Affordable Care Act outside the Capitol Building in Washington, U.S., March 22, 2017.

USC-Brookings Schaeffer on Health Policy

What to watch for in the individual health insurance market

Sobin Lee, Will Palmisano, and Paul B. Ginsburg

Thursday, March 8, 2018

U.S. President Donald Trump congratulates House Speaker Paul Ryan

Podcast Episode

On the AHCA vote and the future of American health care

Matthew Fiedler

Thursday, May 4, 2017

View All Multimedia

More on Health Care Industry

Building resilience into US prescription drug supply chains

Minje Park, Rena M. Conti, Marta E. Wosińska, Ergun Ozlem, Wallace J. Hopp, and Erin R. Fox

Monday, January 30, 2023

Medicaid and Accelerated Approval: Spending on drugs with and without proven clinical benefits

Rachel E. Sachs, Shelley A. Jazowski, Kyle A. Gavulic, Julie M. Donohue, and Stacie B. Dusetzina

Wednesday, January 11, 2023

Reforming the Medicare Part D benefit design: Financial implications for beneficiaries, private plans, drug manufacturers, and the federal government

Erin Trish, Katrina Kaiser, Jeanai Celestin, and Geoffrey Joyce

Wednesday, January 11, 2023

Comments on the draft harmonized system code list of critical supply chains

Marta E. Wosińska and Rena M. Conti

Monday, November 7, 2022

red and blue threads pulling on a stethoscope.

Why political polarization won’t thwart better care for older adults

Thursday, October 13, 2022

Insurers negotiate lower hospital prices for HIX than for commercial groups

Samantha Randall, Erin Duffy, Sarah Green, and Erin Trish

Wednesday, September 21, 2022

View All

Reports

Drug rebates in Medicare Part D

Rebuilding the US medical supply chain

Wall Street Comes to Washington health care roundtable

Fellow and Associate Director - USC-Brookings Schaeffer Initiative for Health Policy

Senior Fellow - Economic Studies

Director - USC-Brookings Schaeffer Initiative for Health Policy

Co-director - USC Schaeffer Center for Health Policy & Economics

Nonresident Fellow - Economic Studies, USC-Brookings Schaeffer Initiative for Health Policy